Pre-vaporization formulation for controlling acidity in an e-vaping device

Patent metadata

Field	Value
Publication number	US-10327472-B2
Application number	US-201514865813-A
Country	US
Kind code	B2
Filing date	Sep 25, 2015
Priority date	Sep 25, 2015
Publication date	Jun 25, 2019
Grant date	Jun 25, 2019

Abstract

A pre-vaporization formulation for an e-vaping device includes a vapor former, optionally water, nicotine, nicotine bitartrate and an acid. The pH of the pre-vaporization formulation is between about 4 and about 6. The acid can include one or more of pyruvic acid, formic acid, oxalic acid, glycolic acid, acetic acid, isovaleric acid, valeric acid, propionic acid, octanoic acid, lactic acid, sorbic acid, malic acid, tartaric acid, succinic acid, citric acid, benzoic acid, oleic acid, aconitic acid, butyric acid, cinnamic acid, decanoic acid, 3,7-diemthyl-6-octenoic acid, 1-glutamic acid, heptanoic acid, hexanoic acid, 3-hexenoic acid, trans-2-hexenoic acid, isobutyric acid, lauric acid, 2-methylbutyric acid, 2-methylvaleric acid, myristic acid, nonanoic acid, palmitic acid, 4-pentenoic acid, phenylacetic acid, 3-phenylpropionic acid, hydrochloric acid, phosphoric acid and sulfuric acid.

First claim

The invention claimed is:

1. A pre-vaporization formulation of an e-vaping device, the pre-vaporization formulation comprising:
a vapor former;
nicotine;
nicotine bitartrate in a concentration of about 0.5% to about 2%; and
a combination of a plurality of acids;
wherein a pH of the pre-vaporization formulation is between about 4 and about 6, and
wherein the combination of the plurality of acids includes formic acid, oxalic acid, glycolic acid, acetic acid, isovaleric acid, valeric acid, propionic acid, octanoic acid, lactic acid, sorbic acid, malic acid, tartaric acid, succinic acid, citric acid, benzoic acid, oleic acid, aconitic acid, butyric acid, cinnamic acid, decanoic acid, 3,7-dimethyl-6-octenoic acid, 1-glutamic acid, heptanoic acid, hexanoic acid, 3-hexenoic acid, trans-2-hexenoic acid, isobutyric acid, lauric acid, 2-methylbutyric acid, 2-methvlvaleric acid, myristic acid, nonanoic acid, palmitic acid, 4-pentenoic acid, phenylacetic acid, 3-phenvlpropionic acid, hydrochloric acid, phosphoric acid and sulfuric acid.

2. The pre-vaporization formulation of claim 1 , wherein the pH of the pre-vaporization formulation is between about 4.5 and 5.5.

3. The pre-vaporization formulation of claim 1 , wherein the pH of the pre-vaporization formulation is about 5.

4. The pre-vaporization formulation of claim 1 , wherein a concentration of the combination of a plurality of acids is between about 0.25% and about 2%.

5. The pre-vaporization formulation of claim 1 , wherein the combination of acids includes equal parts of each of the tartaric acid and the acetic acid.

6. The pre-vaporization formulation of claim 1 , wherein a concentration of the nicotine is between about 1.5% by weight and about 6% by weight.

7. The pre-vaporization formulation of claim 1 , wherein a concentration of the nicotine bitartrate is between about 0.5% by weight and about 1.5% by weight.

8. The pre-vaporization formulation of claim 1 , wherein the concentration of nicotine bitartrate is about 0.5% to 1% and wherein a concentration of a mixture of about equal parts tartaric acid and acetic acid is about 0.5% to 1%.

9. The pre-vaporization formulation of claim 1 , wherein the concentration of nicotine bitartrate is about 0.5% to 1% and wherein a concentration of hydrochloric acid is about 0.01% to 0.1%.

10. The pre-vaporization formulation of claim 1 , wherein a concentration of oleic acid is about 0.5% to 1% and a concentration of a mixture of about equal parts tartaric acid and acetic acid is about 0.5% to 1.5%.

11. The pre-vaporization formulation of claim 1 , wherein a concentration of sorbic acid is about 0.1% to 0.5%, a concentration of tartaric acid is about 0.1% to 0.5%.

12. The pre-vaporization formulation of claim 1 , wherein a concentration of succinic acid is about 0.1% to 0.5%, and a concentration of lactic acid is about 0.1% to 0.5%.

13. The pre-vaporization formulation of claim 1 , wherein the combination of acids includes about 15% to 35% of each of the tartaric acid and the acetic acid.

14. The pre-vaporization formulation of claim 1 , wherein the combination of acids includes about 10% to 40% of each of the tartaric acid and the acetic acid.

15. The pre-vaporization formulation of claim 1 , wherein the combination of acids includes about 5% to 45% of each of the tartaric acid and the acetic acid.

16. The pre-vaporization formulation of claim 1 , wherein the combination of acids includes less than about 50% of each of the tartaric acid and the acetic acid.

17. An e-vaping device, comprising:
a cartomizer including a reservoir holding a pre-vaporization formulation, a mouth piece and a heater configured to heat the pre-vaporization formulation; and
a power supply section removably connected to the cartomizer via a connector and including a sensor housed in a housing, a sensor holder holding the sensor, and a power source disposed in the power supply section and configured to supply power to the heater;
wherein the pre-vaporization formulation includes:
a vapor former;
nicotine;
nicotine bitartrate in a concentration of about 0 . 5 % to about 2 %; and
a combination of acids;

wherein a pH of the pre-vaporization formulation is between about 4 and about 6, and
wherein the combination of acids includes formic acid, oxalic acid, glycolic acid, acetic acid, isovaleric acid, valeric acid, propionic acid, octanoic acid, lactic acid, sorbic acid, malic acid, tartaric acid, succinic acid, citric acid, benzoic acid, oleic acid, aconitic acid, butyric acid, cinnamic acid, decanoic acid, 3,7-dimethyl-6-octenoic acid, 1-glutamic acid, heptanoic acid, hexanoic acid, 3-hexenoic acid, trans-2-hexenoic acid, isobutyric acid, lauric acid, 2-methylbutyric acid, 2-methylvaleric acid, myristic acid, nonanoic acid, palmitic acid, 4-pentenoic acid, phenylacetic acid, 3-phenylpropionic acid, hydrochloric acid, phosphoric acid and sulfuric acid.

18. The pre-vaporization formulation of claim 17 , wherein the concentration of nicotine bitartrate is about 0.5% to 1%, and a concentration of a mixture of tartaric acid and acetic acid is about 0.5% to 1%.

19. The pre-vaporization formulation of claim 17 , wherein the concentration of nicotine bitartrate is about 0.5% to 1%, and a concentration of hydrochloric acid is about 0.01% to 0.1%.

20. The pre-vaporization formulation of claim 17 , wherein a concentration of oleic acid is about 0.5% to 1%, and a concentration of a mixture of tartaric acid and acetic acid is about 0.5% to 1.5.

21. The pre-vaporization formulation of claim 17 , wherein a concentration of sorbic acid is about 0.1% to 0.5% and a concentration of tartaric acid is about 0.1% to 0.5%.

22. The pre-vaporization formulation of claim 17 , wherein a concentration of succinic acid is about 0.1% to 0.5% and a concentration of lactic acid is about 0.1% to 0.5%.

23. A pre-vaporization formulation of an e-vaping device, the pre-vaporization formulation comprising:
a vapor former including of propylene glycol, glycerin, or both propylene glycol and glycerin;
nicotine at a concentration of about 6%;
nicotine salt at a concentration of about 0.5% to about 1%; and
a combination of acids including formic acid, oxalic acid, glycolic acid, acetic acid, isovaleric acid, valeric acid, propionic acid, octanoic acid, lactic acid, sorbic acid, malic acid, tartaric acid, succinic acid, citric acid, benzoic acid, oleic acid, aconitic acid, butyric acid, cinnamic acid, decanoic acid, 3,7-dimethyl-6-octenoic acid, 1-glutamic acid, heptanoic acid, hexanoic acid, 3-hexenoic acid, trans-2-hexenoic acid, isobutyric acid, lauric acid, 2-methylbutyric acid, 2-methylvaleric acid, myristic acid, nonanoic acid, palmitic acid, 4-pentenoic acid, phenylacetic acid, 3-phenylpropionic acid, hydrochloric acid, phosphoric acid and sulfuric acid;
wherein a pH of the pre-vaporization formulation is about 6.

Assignees

• Altria Client Services Llc

Inventors

• Li San
• Karles Georgios
• Kobal Gerd
• Li Weiling
• Secrist Rebecca
• Jarquin Maria Del Carmen
• Di Novi Christopher
• Pithawalla Yezdi
• Kane David

Classifications

• A24B15/16

  of tobacco substitutes · CPC title

• A61K9/007

  Pulmonary tract; Aromatherapy · CPC title

• A24B15/42

  by organic and inorganic substances {(A24B15/281 takes precedence)} · CPC title

• A24B15/167 Primary

  in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes · CPC title

• A24B15/30 Primary

  by organic substances {(A24B15/281 takes precedence)} · CPC title